Technical Analysis for TBPMF - Tetra Bio-Pharma Inc.

Grade Last Price % Change Price Change
grade D 0.2646 2.72% 0.0070
TBPMF closed up 2.72 percent on Tuesday, February 25, 2020, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical TBPMF trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish 2.72%
1,2,3 Pullback Bullish Bullish Swing Setup 2.72%
Wide Bands Range Expansion 2.72%
Down 3 Days in a Row Weakness 2.72%
Oversold Stochastic Weakness 2.72%
Older signals for TBPMF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Tetra Bio-Pharma Inc., a development stage company, engages in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements in Canada. The company offers Rx Princeps, a pharmaceutical-grade product based on its blend of smokable dried cannabis inhalation device. Its product pipeline includes PPP001, a dried cannabis prescription drug for advanced cancer pain; PPP002, a slow release formulation of Dronabinol for treating chemotherapy induced and chronic pain; PPP003, an ocular formulation of cannibinoids for the treatment of ocular pain and inflammation; PPP004, a topical cream for neuropathic pain; and PPP005, a cannabis oil capsule for the treatment of chronic pain. The company is also developing natural health products, including AGT001, a topical product for pain management; AGT002, an oral product line for cardiovascular disease prevention, athletic performance, and well-being; AGT003, a topical product for skin care; AGT004, a topical product for women; and Munchies B Gone gum. Tetra Bio-Pharma Inc. has a license and development agreement with IntelGenx Corp. for the development and commercialization of a drug product containing dronabinol; and Panag Pharma Inc. for the license and development of ocular and topical drugs. It also has research and development agreement with Constance Therapeutics, Inc. for the manufacture, process, prepare, study, research, and engage in clinical trials using the licensed products; co-development, marketing, and commercialization agreements with Neptune Technologies & Bioressources Inc. and Storz & Bickel; and strategic partnership with Sirius Air Solutions Inc. for suppling a specialized cannabis smoke air purifying system and a mask designed for law and emergency responders. The company was formerly known as GrowPros Cannabis Ventures Inc. and changed its name to Tetra Bio-Pharma Inc. in September 2016. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.
Medicine Cannabis Clinical Medicine Entheogens Euphoriants Medicinal Plants Health Sciences Medical Cannabis Pain Chemotherapy Inflammation Pain Management Cardiovascular Disease Appetite Stimulants Antiemetics Chronic Pain Natural Health Products Neuropathic Pain Bio Pharmaceuticals Cardiovascular Disease Prevention Dronabinol Topical Product

Is TBPMF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.6045
52 Week Low 0.139
Average Volume 188,039
200-Day Moving Average 0.2880
50-Day Moving Average 0.3614
20-Day Moving Average 0.3483
10-Day Moving Average 0.3086
Average True Range 0.0485
ADX 32.38
+DI 29.0885
-DI 19.5007
Chandelier Exit (Long, 3 ATRs ) 0.4590
Chandelier Exit (Short, 3 ATRs ) 0.4008
Upper Bollinger Band 0.4682
Lower Bollinger Band 0.2284
Percent B (%b) 0.15
BandWidth 68.8487
MACD Line -0.0231
MACD Signal Line -0.0122
MACD Histogram -0.0108
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3153
Resistance 3 (R3) 0.3187 0.3053 0.3069
Resistance 2 (R2) 0.3053 0.2924 0.3036 0.3040
Resistance 1 (R1) 0.2849 0.2844 0.2782 0.2815 0.3012
Pivot Point 0.2715 0.2715 0.2681 0.2698 0.2715
Support 1 (S1) 0.2511 0.2586 0.2444 0.2477 0.2280
Support 2 (S2) 0.2377 0.2506 0.2360 0.2252
Support 3 (S3) 0.2173 0.2377 0.2224
Support 4 (S4) 0.2139